Prothena Corp. plc Stock
Price
Target price
€9.70
€9.70
1.040%
0.1
1.040%
€26.75
09:10 / Tradegate
WKN: A1KAVV / Symbol: PRTA / Name: Prothena Corp / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Prothena Corp. plc Stock
There is an upward development for Prothena Corp. plc compared to yesterday, with an increase of €0.10 (1.040%).
With 18 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 26 € there is potential for a 168.04% increase which would mean more than doubling the current price of 9.7 € for Prothena Corp. plc.
Our community identified positive and negative aspects for Prothena Corp. plc stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Prothena Corp. plc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Prothena Corp. plc in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prothena Corp. plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prothena Corp. plc | 1.040% | 6.667% | 4.348% | -27.273% | -33.793% | -84.436% | 6.077% |
| Ardelyx Inc. | -1.930% | -3.964% | 1.395% | -6.825% | -0.463% | 180.604% | -5.108% |
| Krystal Biotech | -0.310% | 0.793% | 7.744% | 6.689% | 25.230% | 150.789% | - |
| Evolus Inc | 0.890% | -4.274% | 0.901% | -54.098% | -46.667% | -18.248% | 84.697% |
Comments
Prothena (NASDAQ:PRTA) had its price target raised by analysts at HC Wainwright from $20.00 to $30.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) was given a new $20.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) had its price target lowered by analysts at Piper Sandler from $81.00 to $15.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
